Effect of Bridging Therapy on Neuron-Specific Enolase, S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein in Patients with Acute Cerebral Infarction

doi:10.3969/j.issn.1673-5765.2023.11.008

Abstract

Abstract: Objective To explore the effect of bridging therapy on the related biochemical markers of serum nerve injury in acute cerebral infarction patients with anterior circulation large vessel occlusion and its clinical efficiency, in order to provide evidence for the selection of treatment methods for acute cerebral infarction.
Methods The patients with acute cerebral infarction with occlusion of large vessels in anterior intracranial circulation from October 2018 to June 2020 were analyzed retrospectively. According to whether bridging therapy was taken, they were divided into control group (intravenous thrombolysis group) and observation group (bridging therapy group). The treatment effective (NIHSS score decreased by≥4 points or NIHSS score of 0 point) rate between the two groups at 24 h
and 14 d after treatment was analyzed. The good prognosis (mRS score≤2 points) rate and
self-care (Barthel index>60) rate of normal living ability between two groups at 30 d, 90 d and 180 d
after treatment, the incidence of intracerebral hemorrhage during hospitalization, and the related biochemical markers of serum nerve injury [neuron-specific enolase (NSE), S100 calcium-binding protein B (S100B) and glial fibrillary acidic protein (GFAP)] before and at 3 d, 7 d and 14 d after treatment were also analyzed. Logistic regression model based on mixed effects and linear mixed effects model were used for statistical analysis of prognostic indicators.
Results Multivariate analysis showed that the treatment effective rate of the observation group was 3.35 times higher than that of the control group (OR 3.35, 95%CI 1.10-10.13, P=0.041). The good prognosis rate of the observation group may be 4.12 times higher than that of the control group (OR 4.12, 95%CI 1.14-14.82, P=0.035). The self-care rate of normal living ability in the observation group was similar to that in the control group (OR 1.47, 95%CI 0.28-7.68, P=0.648). There was no significant difference in the incidence of intracerebral hemorrhage between the observation group and the control group (7.4% vs. 8.7%, P=1.000). The levels of NSE, S100B and GFAP in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.001).
Conclusions Compared with simple intravenous thrombolysis, bridging therapy can significantly reduce NSE, S100B and GFAP in acute cerebral infarction patients with anterior circulation large vessel occlusion, and improve clinical efficiency.

Key words: Bridging therapy; Cerebral infarction; Clinical effect; Nerve injury; Neuron-specific enolase; S100 calcium-binding protein B; Glial fibrillary acidic protein

摘要： 目的探讨桥接治疗对前循环大血管闭塞急性脑梗死患者血清神经损伤相关生化标志物的影响以及临床疗效，为急性脑梗死治疗方式的选择提供参考依据。
方法回顾性分析2018年10月—2020年6月前循环大血管闭塞的急性脑梗死患者的病历资料，根据是否采取桥接治疗分为对照组（静脉溶栓组）和观察组（桥接治疗组）。统计两组在治疗后24 h、14 d的治疗有效（NIHSS评分下降≥4分或NIHSS评分0分）率，治疗后30 d、90 d及180 d的良好预后
（mRS评分≤2分）率及日常生活能力自理（Barthel指数＞60分）率，住院期间脑出血发生率，治疗前以及治疗后3 d、7 d及14 d神经元特异性烯醇化酶（neuron-specific enolase，NSE）、S100钙结合蛋白B（S100 calcium-binding protein B，S100B）及胶质纤维酸性蛋白（glial fibrillary acidic protein，GFAP）水平。采用基于混合效应的logistic回归模型、线性混合效应模型进行预后指标的统计分析。
结果多因素分析结果显示：观察组的治疗有效率是对照组的3.35倍（OR 3.35，95%CI 1.10～10.13，P=0.041）；观察组的良好预后率是对照组的4.12倍（OR 4.12，95%CI 1.14～14.82，P=0.035）；观察组的日常生活能力自理率与对照组相当（OR 1.47，95%CI 0.28～7.68，P=0.648）；观察组与对照组脑出血发生率差异无统计学意义（7.4% vs. 8.7%，P=1.000）；观察组NSE、S100B、GFAP水平低于对照组，差异具有统计学意义（P<0.001）。
结论对于前循环大血管闭塞的急性脑梗死患者，与单纯静脉溶栓相比，桥接治疗可显著降低患者NSE、S100B及GFAP水平，提高临床疗效。

关键词: 桥接治疗; 脑梗死; 临床疗效; 神经损伤; 神经元特异性烯醇化酶; S100钙结合蛋白B; 胶质纤维酸性蛋白

YANG Huijie, ZHAO Qian, DU Jie, LYU Xiaofei, PENG Yingjuan, QI Lin. Effect of Bridging Therapy on Neuron-Specific Enolase, S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein in Patients with Acute Cerebral Infarction[J]. Chinese Journal of Stroke, 2023, 18(11): 1268-1276.

杨会杰, 赵倩, 杜洁, 吕晓飞, 彭莹娟, 齐林. 桥接治疗对急性脑梗死患者神经元特异性烯醇化酶、S100钙结合蛋白B、胶质纤维酸性蛋白的影响[J]. 中国卒中杂志, 2023, 18(11): 1268-1276.

References

[1] 中国老年医学学会急诊医学分会，中华医学会急诊医学分会卒中学组，中国卒中学会急救医学分会. 急性缺血性脑卒中急诊急救中国专家共识2018[J]. 中国卒中杂志，2018，13（9）：956-967.
Emergency Medicine Branch of Chinese Geriatrics Society，Stroke Group of Chinese Society of Emergency Medicine，Emergency Medicine Branch of Chinese Stroke Association. Chinese experts consensus on emergency management of acute ischemic stroke 2018[J]. Chin J Stroke，2018，13（9）：956-967.
[2] JAUCH E C，SAVER J L，ADAMS H P Jr，et al. Guidelines for the early management of patients with acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke，2013，44（3）：870-947.
[3] 中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2018[J]. 中国卒中杂志，2018，13（7）：706-729.
Chinese Stroke Association，Chinese Interventional Neuroradiology Society，Intervention Group of Committee of Stroke Prevention and Control of Chinese Preventive Medicine Association. Chinese guideline for endovascular treatment of acute ischemic stroke 2018[J]. Chin J Stroke，2018，13（7）：706-729.
[4] ASADI H，DOWLING R，YAN B，et al. Advances in endovascular treatment of acute ischaemic stroke[J]. Intern Med J，2015，45（8）：798-805.
[5] 热孜亚·阿布都许库尔，吕珊，贺耀德，等. 急性缺血性卒中血管再通治疗研究历程[J]. 协和医学杂志，2020，11（2）：162-169.
ABUDUXUKUER R，LYU S，HE Y D，et al. Rearch course of reperfusion therapy for acute ischemic stroke[J]. Med J PUMCH，2020，11（2）：162-169.
[6] 陈俊武. 静脉溶栓桥接支架取栓与单纯支架取栓治疗颅内大血管急性闭塞效果和安全性的比较[J]. 临床医学，2020，40（3）：53-54.
CHEN J W. Comparison of efficacy and safety between intravenous thrombolysis bridging stent thrombectomy and simple stent thrombectomy in the treatment of acute occlusion of intracranial large vessels[J]. Clin Med，2020，40（3）：53-54.
[7] 谢凯凯，曹文锋，项正兵，等. 重组组织型纤溶酶原激活剂静脉溶栓与桥接治疗对前循环大血管闭塞的临床疗效比较[J]. 中华脑血管病杂志（电子版），2020，14（2）：90-95.
XIE K K，CAO W F，XIANG Z B，et al. The comparison of rt-PA intravenous thrombolysis and rt-PA intravenous thrombolysis combined with mechanical thrombectomy in anterior circulation stroke due to the large vessel occlusion[J]. Chin J Cerebrovasc Dis（Electronic Edition），2020，14（2）：90-95.
[8] 迟相林，李振光，郭兆荣，等. NSE、S100B蛋白、MBP、GFAP与缺血性脑卒中临床相关性研究进展[J]. 中国神经免疫学和神经病学杂志，2008，15（4）：308-310.
CHI X L，LI Z G，GUO Z R，et al. Research progress on the clinical correlation between NSE，S100B，MBP，GFAP and ischemic stroke[J]. Chin J Neuroimmunol Neurol，2008，15（4）：308-310.
[9] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志，2018，51（9）：666-682.
Chinese Society of Neurology，Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol，2018，51（9）：666-682.
[10] DEMAERSCHALK B M，KLEINDORFER D O，ADEOYE O M，et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke：a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke，2016，47（2）：581-641.
[11] POWERS J W，RABINSTEIN A A，ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2019，50（12）：e344-e418[2022-03-02]. https://doi.org/10.1161/STR.0000000000000211.
[12] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组，中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性脑卒中早期血管内介入诊疗指南2018[J]. 中华神经科杂志，2018，51（9）：683-691.
Chinese Society of Neurology，Chinese Stroke Society，Neurovascular Intervention Group of Chinese Society of Neurology. Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018[J]. Chin J Neurol，2018，51（9）：683-691.
[13] 周溱，周江，马艳，等. 静脉溶栓桥接支架取栓与直接支架取栓治疗颅内大血管急性闭塞效果分析[J]. 微循环学杂志，2019，29（2）：24-27，32.
ZHOU Z，ZHOU J，MA Y，et al. Efficacy analysis of intravenous thrombolysis bridging stent mechanical thrombolysis and simple stent mechanical thrombolysis for the treatment of acute intracranial large-vessel occlusion[J]. Chin J Micro，2019，29（2）：24-27，32.
[14] YI H J，SUNG J H，LEE D H. Bridging intravenous thrombolysis before mechanical thrombectomy for large artery occlusion may be detrimental with thrombus fragmentation[J]. Curr Neurovasc Res，2020，17（1）：18-26.
[15] 胡杨真，胡列计，黄婉洁. 阿替普酶静脉溶栓桥接Solitaire AB支架取栓术治疗急性脑梗死的疗效分析[J]. 卒中与神经疾病，2019，26（2）：148-152.
HU Y Z，HU L J，HUANG W J. Therapeutic effect of intraveneous thrombolysis by alteplase bridged endovascular thrombectomy with the Solitaire AB stent retrieverin treatment of patients with acute cerebral infarction[J]. Stroke Nerv Dis，2019，26（2）：148-152.
[16] 邱玉发，王驰，舒张，等. 县级综合卒中中心应用Solitaire支架机械取栓联合Navien导管抽吸技术治疗急性前循环大血管闭塞的效果分析[J]. 中国脑血管病杂志，2019，16（12）：637-641.
QIU Y F，WANG C，SHU Z，et al. Effect analysis of Solitaire stent combined with Navien aspiration for large vessel occlusion of anterior circulation performed in county comprehensive stroke centers[J]. Chin J Cerebrovasc Dis，2019，16（12）：637-641.
[17] VAN DEN BERG L A，DIJKGRAAF M G，ERKHEMER O A，et al. Two-year outcome after endovascular treatment for acute ischemic stroke[J]. N Engl J Med，2017，376（14）：1341-1349.
[18] DÁVALOS A，COBO E，MOLINA C A，et al. Safety and efficacy of thrombectomy in acute ischaemic stroke（REVASCAT）：1-year follow-up of a randomised open-label trial[J]. Lancet Neurol，2017，16（5）：369-376.
[19] CAMPBELL B C，MITCHELL P J，KLEINIG T J，et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med，2015，372（11）：1009-1018.
[20] GOYAL M，DEMCHUK A M，MENON B K，et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med，2015，372（11）：1019-1030.
[21] SAVER J L，GOYAL M，BONAFE A，et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med，2015，372（24）：2285-2295.
[22] 曲明卫，王立敏，朱兰，等. 血清NSE、MMP-10、s100β与急性脑梗死患者神经功能缺损程度的关系研究[J]. 神经损伤与功能重建，2020，15（7）：408-409.
QU M W，WANG L M，ZHU L，et al. A study on NSE，MMP-10 and s100β between neurological function deficiency and acute cerebral infarction patients[J]. Neural Injury Funct Reconstruct，2020，15（7）：408-409.
[23] 刘萍. 急性期脑梗死患者血清UCH-L1和GFAP水平及其与病情和神经功能缺损程度的相关性研究[J]. 实用医院临床杂志，2019，16（2）：173-176.
LIU P. The association of serum levels of UCH-L1 and GFAP with patient’s condition and degree of nervous functional defects during acute period of cerebral infarction[J]. Prac J Clini Med，2019，16（2）：173-176.
[24] 乐婷，娄萍，路青山. 急性缺血性卒中静脉溶栓桥接血管内治疗的疗效和安全性[J]. 中国卒中杂志，2019，14（12）：1232-1236.
YUE T，LOU P，LU Q S. Efficacy and safety of intravenous thrombolysis bridging endovascular therapy for acute ischemic stroke[J]. Chin J Stroke，2019，14（12）：1232-1236.
[25] 李双霜，余震，曹玉倩，等. 静脉溶栓桥接与直接机械取栓治疗急性缺血性卒中的比较[J]. 国际脑血管病杂志，2018，26（5）：353-357.
LI S S，YU Z，CAO Y Q，et al. Bridging with intravenous thrombolysis versus direct endovascular thrombectomy for acute ischemic stroke[J]. Int J Cerebrovasc Dis，2018，26（5）：353-357.
[26] 宋黎，李斌. 静脉溶栓桥接支架取栓治疗急性颅内大血管闭塞患者临床疗效评价[J]. 云南医药，2020，41（6）：542-544.
SONG L，LI B. Clinical efficacy evaluation of intravenous thrombolysis bridging stent thrombectomy in the treatment of acute intracranial large vessel occlusion patients[J]. Med Pharm Yunnan，2020，41（6）：542-544.